Outcomes and Management of Patients with Cushing’s Disease without Pathological Confirmation of Tumor Resection after Transsphenoidal Surgery
Authors:
Open Access
- 1 September 2007
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (9) , 3383-3388
Abstract
Context: Despite the success of transsphenoidal surgery (TSS) for the treatment of Cushing’s disease, in a number of cases, an ACTH-staining pituitary adenoma is not identified histologically. The clinical significance of lack of histological confirmation remains unclear. Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center. Patients: Of 490 TSS procedures for Cushing’s disease between 1993 and 2004, we identified 111 cases without histological adenoma confirmation. Main Outcome Measure: Remission and recurrence of Cushing’s disease were measured. Results: Overall, 50% of these patients achieved remission, a figure lower than for our entire series (79%) and for patients with histological confirmation of an ACTH-staining adenoma (88%) (P < 0.001). Patients with a history of two prior TSS achieved remission less often than patients with a history of fewer TSS (P = 0.026). No other factors influenced remission rates. Although the overall recurrence rate (21%, seven of 33 evaluated) was not different from previously published long-term studies, in three of seven cases of recurrence, early recurrences were noted between 2 and 4 months after remission. In patients who did not achieve remission, the most common and effective treatment options were repeat TSS, γ-knife radiosurgery, and bilateral adrenalectomy. Conclusion: The lower remission rate in patients without histological evidence of an adenoma is most likely a result of a decreased rate of adenoma extirpation. The incidence of early recurrence may be a unique feature of this patient population; patients without histological confirmation of tumor resection therefore require close and consistent monitoring postoperatively.Keywords
This publication has 17 references indexed in Scilit:
- CLINICAL REVIEW: The Strategy of Immediate Reoperation for Transsphenoidal Surgery for Cushing’s DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2005
- Pituitary Surgery and Postoperative Management in Cushing's DiseaseEndocrinology and Metabolism Clinics of North America, 2005
- Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term ResultsThe Journal of Clinical Endocrinology & Metabolism, 2004
- Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression testJournal of Neurosurgery, 2003
- Undetectable postoperative cortisol does not always predict long‐term remission in Cushing’s disease: a single centre audit*Clinical Endocrinology, 2002
- Assessment of Cure and Recurrence After Pituitary Surgery for Cushing's DiseaseActa Neurochirurgica, 2001
- Treatment of Cushing’s disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-upJournal of Endocrinological Investigation, 1996
- Predictive Factors for Initial Cure and Relapse Rate After Pituitary Surgery for Cushing’s DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1989
- Transsphenoidal Microsurgery for Cushing DiseaseAnnals of Internal Medicine, 1988
- Transsphenoidal Pituitary Surgery for the Treatment of Cushing' s Disease: Results in 64 Patients and Long Term Follow-Up Studies*The Journal of Clinical Endocrinology & Metabolism, 1988